INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:INVX • US4576511079

24.09 USD
-0.85 (-3.41%)
At close: Feb 5, 2026
24.09 USD
0 (0%)
After Hours: 2/5/2026, 8:04:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to INVX. INVX was compared to 61 industry peers in the Energy Equipment & Services industry. While INVX has a great health rating, its profitability is only average at the moment. INVX is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make INVX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • INVX had positive earnings in the past year.
  • In the past year INVX had a positive cash flow from operations.
  • In multiple years INVX reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: INVX reported negative operating cash flow in multiple years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • INVX's Return On Assets of 8.06% is amongst the best of the industry. INVX outperforms 86.89% of its industry peers.
  • INVX's Return On Equity of 9.73% is fine compared to the rest of the industry. INVX outperforms 68.85% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.34%, INVX is in the better half of the industry, outperforming 68.85% of the companies in the same industry.
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROIC 8.34%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • With an excellent Profit Margin value of 10.58%, INVX belongs to the best of the industry, outperforming 86.89% of the companies in the same industry.
  • In the last couple of years the Profit Margin of INVX has grown nicely.
  • With a decent Operating Margin value of 12.21%, INVX is doing good in the industry, outperforming 67.21% of the companies in the same industry.
  • INVX's Operating Margin has improved in the last couple of years.
  • The Gross Margin of INVX (32.35%) is better than 72.13% of its industry peers.
  • INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • INVX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • INVX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, INVX has more shares outstanding
  • The debt/assets ratio for INVX is higher compared to a year ago.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • INVX has an Altman-Z score of 6.71. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
  • INVX's Altman-Z score of 6.71 is amongst the best of the industry. INVX outperforms 100.00% of its industry peers.
  • INVX has a debt to FCF ratio of 0.19. This is a very positive value and a sign of high solvency as it would only need 0.19 years to pay back of all of its debts.
  • INVX's Debt to FCF ratio of 0.19 is amongst the best of the industry. INVX outperforms 93.44% of its industry peers.
  • INVX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.02, INVX belongs to the top of the industry, outperforming 88.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Altman-Z 6.71
ROIC/WACC0.93
WACC8.93%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • INVX has a Current Ratio of 4.78. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.78, INVX belongs to the best of the industry, outperforming 95.08% of the companies in the same industry.
  • A Quick Ratio of 2.93 indicates that INVX has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.93, INVX belongs to the top of the industry, outperforming 93.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 2.93
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 246.15%, which is quite impressive.
  • INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 123.23% yearly.
  • INVX shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.71%.
  • The Revenue has been growing by 9.76% on average over the past years. This is quite good.
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 66.90% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, INVX will show a very strong growth in Revenue. The Revenue will grow by 22.31% on average per year.
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue Next Year97.7%
Revenue Next 2Y43.21%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • INVX is valuated quite expensively with a Price/Earnings ratio of 25.36.
  • Compared to the rest of the industry, the Price/Earnings ratio of INVX is on the same level as its industry peers.
  • INVX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 14.77, INVX is valued correctly.
  • Based on the Price/Forward Earnings ratio, INVX is valued cheaply inside the industry as 83.61% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of INVX to the average of the S&P500 Index (27.20), we can say INVX is valued slightly cheaper.
Industry RankSector Rank
PE 25.36
Fwd PE 14.77
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVX indicates a slightly more expensive valuation: INVX is more expensive than 62.30% of the companies listed in the same industry.
  • 81.97% of the companies in the same industry are more expensive than INVX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.76
EV/EBITDA 9.09
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • INVX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as INVX's earnings are expected to grow with 95.77% in the coming years.
PEG (NY)0.06
PEG (5Y)0.21
EPS Next 2Y160.71%
EPS Next 3Y95.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INNOVEX INTERNATIONAL INC

NYSE:INVX (2/5/2026, 8:04:00 PM)

After market: 24.09 0 (0%)

24.09

-0.85 (-3.41%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-03
Earnings (Next)N/A
Inst Owners47.97%
Inst Owner Change0.49%
Ins Owners1.52%
Ins Owner Change-3.53%
Market Cap1.66B
Revenue(TTM)955.34M
Net Income(TTM)101.12M
Analysts77.78
Price Target25.5 (5.85%)
Short Float %N/A
Short Ratio7.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.31%
Min EPS beat(2)-62.53%
Max EPS beat(2)-24.08%
EPS beat(4)1
Avg EPS beat(4)-15.03%
Min EPS beat(4)-62.53%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-142.72%
EPS beat(12)2
Avg EPS beat(12)-111.91%
EPS beat(16)3
Avg EPS beat(16)-84.71%
Revenue beat(2)1
Avg Revenue beat(2)2.01%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)8.43%
Revenue beat(4)3
Avg Revenue beat(4)5.34%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)36.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.45%
Revenue NY rev (3m)2.07%
Valuation
Industry RankSector Rank
PE 25.36
Fwd PE 14.77
P/S 1.74
P/FCF 11.76
P/OCF 9.49
P/B 1.6
P/tB 2.02
EV/EBITDA 9.09
EPS(TTM)0.95
EY3.94%
EPS(NY)1.63
Fwd EY6.77%
FCF(TTM)2.05
FCFY8.5%
OCF(TTM)2.54
OCFY10.54%
SpS13.86
BVpS15.07
TBVpS11.94
PEG (NY)0.06
PEG (5Y)0.21
Graham Number17.95
Profitability
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROCE 10.56%
ROIC 8.34%
ROICexc 9.79%
ROICexgc 12.7%
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
FCFM 14.78%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Debt/EBITDA 0.12
Cap/Depr 59.02%
Cap/Sales 3.54%
Interest Coverage 80.3
Cash Conversion 100.59%
Profit Quality 139.63%
Current Ratio 4.78
Quick Ratio 2.93
Altman-Z 6.71
F-Score7
WACC8.93%
ROIC/WACC0.93
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%
Revenue Next Year97.7%
Revenue Next 2Y43.21%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%
EBIT growth 1Y95.65%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year100.38%
EBIT Next 3Y37.48%
EBIT Next 5Y29.59%
FCF growth 1Y326.98%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y586.06%
OCF growth 3Y34.47%
OCF growth 5Y44.76%

INNOVEX INTERNATIONAL INC / INVX FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Fairly Valued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 8 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.